PL3778609T3 - Pochodne penamu lub ich sole, kompozycje farmaceutyczne i ich zastosowanie - Google Patents
Pochodne penamu lub ich sole, kompozycje farmaceutyczne i ich zastosowanieInfo
- Publication number
- PL3778609T3 PL3778609T3 PL19781624T PL19781624T PL3778609T3 PL 3778609 T3 PL3778609 T3 PL 3778609T3 PL 19781624 T PL19781624 T PL 19781624T PL 19781624 T PL19781624 T PL 19781624T PL 3778609 T3 PL3778609 T3 PL 3778609T3
- Authority
- PL
- Poland
- Prior art keywords
- salts
- pharmaceutical compositions
- penam derivatives
- penam
- derivatives
- Prior art date
Links
- 150000002959 penams Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
- C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
- C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
- C07D499/64—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
- C07D499/70—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms with hetero rings as additional substituents on the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
- C07D499/76—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with hetero rings directly attached to the carboxamido radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/897—Compounds with substituents other than a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018073568 | 2018-04-06 | ||
| EP19781624.2A EP3778609B1 (en) | 2018-04-06 | 2019-04-05 | Penam derivatives or salts thereof, pharmaceutical compositions and use thereof |
| PCT/JP2019/015176 WO2019194306A1 (ja) | 2018-04-06 | 2019-04-05 | 新規なペナム誘導体又はその塩、医薬組成物及びその応用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3778609T3 true PL3778609T3 (pl) | 2022-04-25 |
Family
ID=68100759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19781624T PL3778609T3 (pl) | 2018-04-06 | 2019-04-05 | Pochodne penamu lub ich sole, kompozycje farmaceutyczne i ich zastosowanie |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US12286440B2 (pl) |
| EP (1) | EP3778609B1 (pl) |
| JP (1) | JP7092869B2 (pl) |
| KR (1) | KR102442994B1 (pl) |
| CN (1) | CN111954673B (pl) |
| AU (1) | AU2019249008B2 (pl) |
| CA (1) | CA3096177C (pl) |
| CY (1) | CY1125078T1 (pl) |
| DK (1) | DK3778609T3 (pl) |
| ES (1) | ES2908044T3 (pl) |
| HR (1) | HRP20220408T1 (pl) |
| LT (1) | LT3778609T (pl) |
| PL (1) | PL3778609T3 (pl) |
| PT (1) | PT3778609T (pl) |
| RS (1) | RS63060B1 (pl) |
| SI (1) | SI3778609T1 (pl) |
| SM (1) | SMT202200150T1 (pl) |
| TW (1) | TWI795549B (pl) |
| WO (1) | WO2019194306A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114531850B (zh) * | 2019-10-04 | 2024-08-06 | 富士胶片株式会社 | 以含有新的青霉素衍生物或其盐以及选自β-内酰胺酶抑制化合物及抗菌性化合物或其盐中的1种以上的化合物为特征的医药组合物及试剂盒 |
| KR102657446B1 (ko) * | 2021-09-27 | 2024-04-17 | 서울대학교산학협력단 | 항균용 조성물 |
| KR20250071123A (ko) | 2023-11-14 | 2025-05-21 | 신재환 | 폴더블 휴대폰 흰지 완전 보호 케이스 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH089627B2 (ja) * | 1986-12-23 | 1996-01-31 | 富山化学工業株式会社 | 新規なペナム誘導体またはその塩 |
| CA2019260C (en) * | 1989-06-22 | 1999-06-29 | Hirokazu Ochiai | Penam derivatives and salts thereof, processes for producing the same and antibacterial agent comprising the same |
| JP2973126B2 (ja) | 1989-06-22 | 1999-11-08 | 富山化学工業株式会社 | 新規なペナム誘導体およびその塩 |
| JP3523664B2 (ja) * | 1992-05-18 | 2004-04-26 | 富山化学工業株式会社 | 新規なペナム誘導体またはその塩 |
| JPH10130272A (ja) * | 1996-10-25 | 1998-05-19 | Toyama Chem Co Ltd | ２−カルボキシペナム誘導体またはその塩の製造法 |
| JP2936404B2 (ja) | 1998-01-16 | 1999-08-23 | 富山化学工業株式会社 | ペナム−３−カルボン酸誘導体の製造法およびペナム−２，３−ジカルボン酸誘導体 |
| TWI547496B (zh) * | 2011-10-04 | 2016-09-01 | 葛蘭素集團公司 | 抗菌化合物 |
| KR20180066264A (ko) * | 2015-12-10 | 2018-06-18 | 나에자-알지엠 파마슈티칼스 유엘씨 | 세펨 화합물, 그의 제조 및 용도 |
-
2019
- 2019-04-03 TW TW108111972A patent/TWI795549B/zh active
- 2019-04-05 SI SI201930168T patent/SI3778609T1/sl unknown
- 2019-04-05 CN CN201980024184.6A patent/CN111954673B/zh active Active
- 2019-04-05 HR HRP20220408TT patent/HRP20220408T1/hr unknown
- 2019-04-05 LT LTEPPCT/JP2019/015176T patent/LT3778609T/lt unknown
- 2019-04-05 AU AU2019249008A patent/AU2019249008B2/en active Active
- 2019-04-05 JP JP2020512335A patent/JP7092869B2/ja active Active
- 2019-04-05 DK DK19781624.2T patent/DK3778609T3/da active
- 2019-04-05 RS RS20220298A patent/RS63060B1/sr unknown
- 2019-04-05 KR KR1020207028336A patent/KR102442994B1/ko active Active
- 2019-04-05 EP EP19781624.2A patent/EP3778609B1/en active Active
- 2019-04-05 SM SM20220150T patent/SMT202200150T1/it unknown
- 2019-04-05 PL PL19781624T patent/PL3778609T3/pl unknown
- 2019-04-05 ES ES19781624T patent/ES2908044T3/es active Active
- 2019-04-05 CA CA3096177A patent/CA3096177C/en active Active
- 2019-04-05 PT PT197816242T patent/PT3778609T/pt unknown
- 2019-04-05 WO PCT/JP2019/015176 patent/WO2019194306A1/ja not_active Ceased
-
2020
- 2020-10-05 US US17/063,110 patent/US12286440B2/en active Active
-
2022
- 2022-03-16 CY CY20221100209T patent/CY1125078T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US12286440B2 (en) | 2025-04-29 |
| EP3778609B1 (en) | 2022-01-26 |
| AU2019249008A1 (en) | 2020-10-22 |
| DK3778609T3 (da) | 2022-03-14 |
| KR20200128556A (ko) | 2020-11-13 |
| LT3778609T (lt) | 2022-04-25 |
| US20210024543A1 (en) | 2021-01-28 |
| AU2019249008B2 (en) | 2021-11-11 |
| CN111954673B (zh) | 2023-09-05 |
| KR102442994B1 (ko) | 2022-09-13 |
| SMT202200150T1 (it) | 2022-05-12 |
| TWI795549B (zh) | 2023-03-11 |
| JP7092869B2 (ja) | 2022-06-28 |
| CN111954673A (zh) | 2020-11-17 |
| JPWO2019194306A1 (ja) | 2021-03-11 |
| RS63060B1 (sr) | 2022-04-29 |
| HRP20220408T1 (hr) | 2022-05-27 |
| CA3096177A1 (en) | 2019-10-10 |
| ES2908044T3 (es) | 2022-04-27 |
| CY1125078T1 (el) | 2024-02-16 |
| PT3778609T (pt) | 2022-03-02 |
| CA3096177C (en) | 2023-12-12 |
| TW202005969A (zh) | 2020-02-01 |
| SI3778609T1 (sl) | 2022-06-30 |
| WO2019194306A1 (ja) | 2019-10-10 |
| EP3778609A4 (en) | 2021-02-17 |
| EP3778609A1 (en) | 2021-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL257481B (en) | Substituted quinolone derivatives, or pharmaceutically acceptable salts or stereoisomers thereof, and pharmaceutical compositions and use thereof | |
| ZA201906451B (en) | 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same | |
| IL282428A (en) | History of pyridinyl sulfonamide, pharmaceutical preparations and their uses | |
| IL273740A (en) | Oral pharmaceutical formulation containing bacteria | |
| SG11202105540YA (en) | 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same | |
| IL273339A (en) | Griseofulbin compound and its medical use | |
| PT3421038T (pt) | Compostos de naftiridina, combinações médicas e sua utilização | |
| EP3381925A4 (en) | Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof | |
| IL267829B (en) | History of new amino-imidazopyridines as Janus kinase inhibitors and their pharmaceutical use | |
| EP3124486A4 (en) | Substituted nitrogen-containing heterocyclic derivatives, pharmaceutical compositions comprising the same and applications of antitumor thereof | |
| GB2590189B (en) | Lycorine derivative, and pharmaceutical composition and use thereof | |
| IL276430A (en) | A pharmaceutical compound, its cures, its formulations, and methods for its preparation and use | |
| IL276323A (en) | 4-Methyldihydropyrimidinone compounds and their pharmaceutical use | |
| SMT202200150T1 (it) | Derivati penamici o loro sali, composizioni farmaceutiche e loro usi | |
| PT3632436T (pt) | Composição farmacêutica compreendendo sais de lenvatinib | |
| IL274868A (en) | History of imidazopyridine and their use as medicine | |
| SG11202103806VA (en) | 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament | |
| EP3604291A4 (en) | COMPOUND OR SALT THEREOF, ANTIVIRAL AGENT AND PHARMACEUTICAL COMPOSITION | |
| HK40060762A (en) | Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same | |
| PL3980403T3 (pl) | Sole montelukastu i zawierające je kompozycje farmaceutyczne | |
| HK40036505A (en) | Novel triazolone derivatives or salts thereof and pharmaceutical compositions comprising the same | |
| HK40028765A (en) | Pharmaceutical formulations of xanthine or xanthine derivatives, and their use |